Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737592 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
A NA study, sponsored by Church & Dwight Company.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02737592: Completed NA study, sponsored by Church & Dwight Company.
NCT02737592 is a NA study that has completed, run by Church & Dwight Company. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737592, a NA study, has completed, sponsored by Church & Dwight Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
To evaluate the safety of a personal lubricant when used at least four times weekly for two weeks (including at least twice weekly during sexual intercourse for subjects with monogamous male partners), in a population consisting of healthy females.
Primary Outcome
Number of subjects with observed local erythema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no irritation, 0.5 = slight, irregular erythema, 1 = mild erythema, 2 = moderate erythema 3 = severe erythema
Interventions
- DEVICE Trojan "Simply Pleasure" Personal Lubricant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02737592 record still lists
NCT02737592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Trojan "Simply Pleasure" Personal Lubricant is the first listed.
NCT02737592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02737592 about?
NCT02737592 is a clinical study titled "A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects". To evaluate the safety of a personal lubricant when used at least four times weekly for two weeks (including at least twice weekly during sexual intercourse for subjects with monogamous male partners), in a population consisting of healthy females.
What is the current status of trial NCT02737592?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2016-03. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02737592?
The interventions under investigation include: Trojan "Simply Pleasure" Personal Lubricant (DEVICE).
Who is sponsoring clinical trial NCT02737592?
This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02737592's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia